Antibody–drug conjugates for lung cancer in the era of personalized oncology
Author:
Publisher
Elsevier BV
Subject
Cancer Research
Reference155 articles.
1. Antibody–drug conjugates for the treatment of solid tumors: clinical experience and latest developments;Nagayama;Target. Oncol.,2017
2. Strategies and challenges for the next generation of antibody-drug conjugates;Beck;Nat. Rev. Drug Discov.,2017
3. The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma;Senter;Nat. Biotechnol.,2012
4. Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study;Pro;J. Clin. Oncol.,2012
5. Ado-trastuzumab emtansine (T-DM1): an antibody–drug conjugate (ADC) for HER2-Positive breast Cancer;Lambert;J. Med. Chem.,2014
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Tunable Multivalent Aptamer-Based DNA Nanostructures To Regulate Multiheteroreceptor-Mediated Tumor Recognition;Journal of the American Chemical Society;2024-01-22
2. EGFR exon 20 insertion mutations and ERBB2 mutations in lung cancer: a narrative review on approved targeted therapies from oral kinase inhibitors to antibody-drug conjugates;Translational Lung Cancer Research;2023-07
3. Nanobodies: a new potential for prostate cancer treatment;Journal of Cancer Research and Clinical Oncology;2023-01-21
4. The mechanism of total ginseng extracts in the treatment of lung cancer progression based on network pharmacology and experimental validation;World Journal of Traditional Chinese Medicine;2023
5. Targeting the epigenetic processes to enhance antitumor immunity in small cell lung cancer;Seminars in Cancer Biology;2022-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3